Home / Decitabine / United States
US ATC L01BC08 · updated 2 Nov 2026
Decitabine shortage in United States
Is there a Decitabine shortage in United States?
Yes. As of 2 Nov 2026, 2 Decitabine products are reported short in United States, the first since 20 Feb 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Decitabine, Injection, 50 mg (NDC 50742-430-01) discontinuation | Ingenus Pharmaceuticals LLC | 20 Feb 2026 | not given | Not stated |
| US | Decitabine, Injection, 50 mg (NDC 68001-573-41) discontinuation | Ingenus Pharmaceuticals LLC | 20 Feb 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).